132 related articles for article (PubMed ID: 6351377)
41. T-cell subsets in a cyclosporin-A treated recipient of cadaveric kidney allograft as defined by theophylline sensitivity and monoclonal antibodies.
Shohat B; Shapira Z; Servadio C
Dev Biol Stand; 1984; 57():361-6. PubMed ID: 6396131
[TBL] [Abstract][Full Text] [Related]
42. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
Andersen CB; Ladefoged SD; Larsen S
APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
[TBL] [Abstract][Full Text] [Related]
43. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy.
Häyry P; von Willebrand E; Ahonen J
Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749
[TBL] [Abstract][Full Text] [Related]
44. An interesting case.
Ramírez-González J; Pérez-Garrido J; Rodríguez-Romo R; Uribe-Uribe N; de Leo C; Morales-Buenrostro LE; Alberú J
Clin Transpl; 2006; ():566-9. PubMed ID: 18365437
[No Abstract] [Full Text] [Related]
45. Identification of mononuclear cell populations infiltrating human renal allografts.
Waltzer WC; Miller F; Arnold A; Anaise D; Rapaport FT
Transplant Proc; 1987 Feb; 19(1 Pt 2):1629-32. PubMed ID: 3547872
[No Abstract] [Full Text] [Related]
46. Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney.
Boukhalfa G; Desmoulière A; Rondeau E; Gabbiani G; Sraer JD
Exp Nephrol; 1996; 4(4):241-7. PubMed ID: 8864727
[TBL] [Abstract][Full Text] [Related]
47. Cyclosporin A: action and side-effects.
Mihatsch MJ; Thiel G; Ryffel B
Toxicol Lett; 1989 Mar; 46(1-3):125-39. PubMed ID: 2650019
[TBL] [Abstract][Full Text] [Related]
48. Rejection and nephrotoxicity. Diagnostic problems with cyclosporine in renal transplantation.
Pichlmayr R; Wonigeit K; Ringe B; Block T; Raab R; Heigel B; Neuhaus P
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():947-60. PubMed ID: 3887390
[No Abstract] [Full Text] [Related]
49. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
[TBL] [Abstract][Full Text] [Related]
50. Interstitial nephritis in Aleutian mink disease. Possible role of cell-mediated immunity against virus-infected tubular epithelial cells.
Mori S; Nose M; Miyazawa M; Kyogoku M; Wolfinbarger JB; Bloom ME
Am J Pathol; 1994 Jun; 144(6):1326-33. PubMed ID: 8203470
[TBL] [Abstract][Full Text] [Related]
51. [T- and B-lymphocyte count in patients awaiting kidney transplantation and retransplantation].
Petrova IV; Baeva LB; Vasil'eva LL; Naumtseva SI; Levitskiĭ ER
Probl Gematol Pereliv Krovi; 1978 Dec; 23(12):14-6. PubMed ID: 364467
[No Abstract] [Full Text] [Related]
52. Histopathology of cyclosporine.
Wallace AC
Transplant Proc; 1985 Aug; 17(4 Suppl 1):117-22. PubMed ID: 3895653
[No Abstract] [Full Text] [Related]
53. Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs. Immunologic characterization of the inflammatory infiltrate.
Bender WL; Whelton A; Beschorner WE; Darwish MO; Hall-Craggs M; Solez K
Am J Med; 1984 Jun; 76(6):1006-12. PubMed ID: 6375363
[TBL] [Abstract][Full Text] [Related]
54. Eosinophil-rich interstitial infiltrate in an allograft biopsy.
Cheunsuchon B; Staffeld-Coit C; Geiger X
Am J Kidney Dis; 2003 May; 41(5):1116-21. PubMed ID: 12722047
[No Abstract] [Full Text] [Related]
55. Acute interstitial nephritis and uveitis syndrome: activated immune cell infiltration in the kidney.
Yoshioka K; Takemura T; Kanasaki M; Akano N; Maki S
Pediatr Nephrol; 1991 Mar; 5(2):232-4. PubMed ID: 2031842
[TBL] [Abstract][Full Text] [Related]
56. Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation. A pilot study.
Hourmant M; Le Mauff B; Le Meur Y; Dantal J; Cantarovich D; Giral M; Caudrelier P; Albericci G; Soulillou JP
Transplantation; 1994 Aug; 58(3):377-80. PubMed ID: 8053064
[No Abstract] [Full Text] [Related]
57. The use of routinely available clinical data in differentiating renal allograft rejection from cyclosporine nephrotoxicity.
Chan GL; Hodge EE; Chang HH
Transplantation; 1989 Dec; 48(6):1075-7. PubMed ID: 2595772
[No Abstract] [Full Text] [Related]
58. Cyclosporine nephrotoxicity can be minimized by careful monitoring of whole blood trough levels.
Uchida K; Nakanisi N; Yamada N; Tominaga Y; Orihara A; Kondo T; Morimoto T; Morozumi K; Kano T; Takagi H
Dev Toxicol Environ Sci; 1986; 14():163-6. PubMed ID: 3549249
[No Abstract] [Full Text] [Related]
59. Lymphocyte monitoring in renal transplantation.
Burton RC
Transplant Proc; 1984 Aug; 16(4):983-7. PubMed ID: 6380063
[No Abstract] [Full Text] [Related]
60. Experimental lipid A-induced nephritis in the dog.
Westenfelder M; Galanos C; Madsen PO
Invest Urol; 1975 Mar; 12(5):337-45. PubMed ID: 1089611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
